FRANCES ABIGAIL MALANTIC: Open Payments
NPI 1780018960 · HAWAIIAN GARDENS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 4 payments from 4 companies in 2025. Trend: 2023 $169 · 2024 $269 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $119 |
| Lilly USA, LLC | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: Ozempic, ZEPBOUND, Kerendia, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
